We found that significant upregulation of EXT1 and EXT2 was closely associated with cardiac fibrosis and heart failure in DCM, which partly explained the potential molecular mechanism of HS biosynthetic activation in DCM. The gene discussed is EXT2; the disease is familial dilated cardiomyopathy.